Centre prohibits selling Coronil as COVID-19 cure


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ centre-prohibits-selling-coronil-covid19-cure
Ayush ministry has only given the approval to sell this specific formulation as an immunity booster and not as a medicinal remedy for COVID-19.

The Union ministry has banned Patanjali from selling Coronil as a cure for COVID-19.

Ayush ministry has only given the approval to sell this specific formulation as an immunity booster and not as a medicinal remedy for COVID-19, it said.  At a press conference in Haridwar, Ramdev insisted the ministry has said that Patanjali did an appropriate job for COVID-19 management.

 However, on Wednesday Yoga guru Ramdev's Patanjali Ayurved stated that there are no Ayush ministry constraints on selling 'Coronil', a drug the company recently inaugurated as medicine for COVID-19 but is now calling it a product to regulate the disease.

"I want to tell people who want to try these medicines that there is no restriction on their sale now and they will be available in a kit everywhere in the country from today," he added, citing Coronil and the two other products Patanjali is promoting together.

Ramdev told the Union ministry had asked him to use the term 'COVID-19 management' in place of 'COVID-19 treatment' and he is obeying the instruction.

Even while backtracking on characterizing Coronil as a treatment for COVID-19, the company stuck to its statement that the drug's examination on mild to moderately ill patients was successful.

Its press note said the examination, conducted after the necessary permissions, showed 100 percent recovery of patients under seven days.

It started that the Ayush ministry has categorically decided that Patanjali had suitably worked on COVID-19 management.

Now there is no disparity of opinion between Ayush ministry and Patanjali, it added.

According to the ministry, Patanjali is authorized to manufacture and dispense its Diva Coronil tablet, Divya Swasari Vati and Divya Anu Talia across India, as per the manufacturing licences awarded by State Licensing Authority, Ayurvedic and Unani Services, Govt of Uttarakhand, it said.

The Uttarakhand department was among the agencies which had challenged Patanjali's claim to have formulated a drug to cure COVID-19. It said the company had only been given a license to produce an immunity booster

Tags : #Coronil #Patanjali #COVID-19

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026